In a busy time on the GLP-1 front, Novo Nordisk on Tuesday reported filing 14 new lawsuits against companies it says are selling unsafe and unapproved compounded drugs claiming to contain semaglutide, the component of its Ozempic and Wegovy meds
In addition to weight loss, Wegovy is FDA-approved to reduce the risk of major adverse cardiovascular events like heart attack and stroke in obese or overweight adults with heart disease
Hiddo Heerspink, PharmD, Ph.D., discusses the exploratory analysis of SURPASS-4 clinical at the 82nd Scientific Sessions of the American Diabetes Association
Once lost, those gains were not fully restored by resuming treatment
Vegetarians, vegans or people with an unbalanced diet can also experience a vitamin B12 deficiency
Replication of SARS-CoV-2 in adipose tissue determines organ and systemic lipid metabolism in hamsters and humans